Affiliation:
1. Department of Chemical Engineering, University of the Philippines Diliman, Quezon City 1101, Philippines
Abstract
Within the field of Philippine folkloric medicine, the utilization of indigenous plants like Euphorbia hirta (tawa-tawa), Carica papaya (papaya), and Psidium guajava (guava) as potential dengue remedies has gained attention. Yet, limited research exists on their comprehensive effects, particularly their anti-dengue activity. This study screened 2944 phytochemicals from various Philippine plants for anti-dengue activity. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling provided 1265 compounds demonstrating pharmacokinetic profiles suitable for human use. Molecular docking targeting the dengue virus NS2b-NS3 protease’s catalytic triad (Asp 75, Ser 135, and His 51) identified ten ligands with higher docking scores than reference compounds idelalisib and nintedanib. Molecular dynamics simulations confirmed the stability of eight of these ligand–protease complexes. Molecular Mechanics/Poisson–Boltzmann Surface Area (MM/PBSA) analysis highlighted six ligands, including veramiline (−80.682 kJ/mol), cyclobranol (−70.943 kJ/mol), chlorogenin (−63.279 kJ/mol), 25beta-Hydroxyverazine (−61.951 kJ/mol), etiolin (−59.923 kJ/mol), and ecliptalbine (−56.932 kJ/mol) with favorable binding energies, high oral bioavailability, and drug-like properties. This integration of traditional medical knowledge with advanced computational drug discovery methods paves new pathways for the development of treatments for dengue.
Reference46 articles.
1. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein;Lee;J. Mol. Graph. Model.,2017
2. Villanueva, R. (2023, March 20). Philippines Logs 220,705 Dengue Cases in 2022, The Philippine Star, Available online: https://www.philstar.com/nation/2023/01/17/2238093/philippines-logs-220705-dengue-cases-2022.
3. Dengvaxia: Age as surrogate for serostatus;Aguiar;Lancet Infect. Dis.,2018
4. Development of antiviral inhibitor against dengue 2 targeting Ns3 protein: In vitro and in silico significant studies;Padmapriya;Acta Trop.,2018
5. Uday, R.V.S., Misra, R., Harika, A., Dolui, S., Saha, A., Pal, U., Ravichandiran, V., and Maiti, N.C. (2021). Dabrafenib, idelalisib and nintedanib act as significant allosteric modulator for dengue NS3 protease. PLoS ONE, 16.